Hsa_circ_0097922 silencing increased the chemotherapy sensitivity of BC to tamoxifen in vitro and in vivo partly through regulating the miR‐876‐3p/ACTN4 axis, which might serve as a potential therapeutic target for BC treatment.348. This evidence concerns the gene ACTN4 and breast cancer.